Doctor’s Guide -- GLASGOW, Scotland -- October 5, 2010 -- Patients with Parkinson’s disease treated with paroxetine or venlafaxine extended-release have achieved improvements in standard measures of depression, according to a study presented here at the 2nd World Parkinson Congress (WPC).
